Pharmacology of Neurotransmitter Release pp 435-477

Part of the Handbook of Experimental Pharmacology book series (HEP, volume 184)

Presynaptic Modulation by Endocannabinoids

  • David M. Lovinger

Modulation of neurotransmitter release by G-protein-coupled receptors (GPCRs) is a prominent presynaptic mechanism for regulation of synaptic transmission. Activation of GPCRs located at the presynaptic terminal can decrease the probability of neurotransmitter release. This presynaptic depression involves activationof Gi/o-type G-proteins that mediate different inhibitory mechanisms, including inhibition of voltage-gated calcium channels, activation of potassium channels, and direct inhibition of the vesicle fusion process. A variety of neurotransmitters and modulatory agents can activate GPCRs that produce presynaptic depression. Among these are lipid metabolites that serve as agonists for GPCRs. The discovery of endocannabinoids and their cognate receptors, including the CB1 receptor, has stimulated intense investigation into the neurophysiological roles of these lipid metabolites. It is now clear that presynaptic depression is the major physiological role for the CB1 receptor. Endocannabinoids activate this receptor mainly via a retrograde signaling process in which these compounds are synthesized in and released from postsynaptic neuronal elements, and travel back to the presynaptic terminal to act on the CB1 receptor. This retrograde endocannabinoid modulation has been implicated in short-term synaptic depression, including suppression of excitatory or inhibitory transmission induced by postsynaptic depolarization and transient synaptic depression induced by activation of postsynaptic GPCRs during agonist treatment or synaptic activation. Endocannabinoids and the CB1 receptor also play a key role in one form of long-term synaptic depression (LTD) that involves a longlasting decrease in neurotransmitter release.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abraham WC, Bear MF (1996) Metaplasticity: the plasticity of synaptic plasticity. Trends Neurosci 19:126-30PubMedGoogle Scholar
  2. Alexander JP, Cravatt BF (2006) The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases. J Am Chem Soc 128 (30):9699-9704PubMedGoogle Scholar
  3. Alger BE (2002) Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 68:247-86PubMedGoogle Scholar
  4. Ameri A, Wilhelm A, Simmet T (1999) Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Br J Pharmacol 126(8):1831-9PubMedGoogle Scholar
  5. Auclair N, Otani S, Soubrie P, Crepel F (2000) Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol 83:3287-93PubMedGoogle Scholar
  6. Azad SC, Monory K, Marsicano G, Cravatt BF, Lutz B, Zieglgansberger W, Rammes G (2004) Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. J Neurosci 24 (44):9953-61PubMedGoogle Scholar
  7. Bacci A, Huguenard JR, Prince DA (2004) Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431(7006):312-16PubMedGoogle Scholar
  8. Bachur NR, Masek K, Melmon KL, Udenfriend S (1965) Fatty acid amides of ethanolamine in mammalian tissues. J Biol Chem 240(3):1019-24PubMedGoogle Scholar
  9. Bamford NS, Zhang H, Schmitz Y, Wu NP, Cepeda C, Levine MS, Schmauss C, Zakharenko SS, Zablow L, Sulzer D (2004) Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 42(4):653-63PubMedGoogle Scholar
  10. Bass NM (1988) The cellular fatty acid binding proteins: aspects of structure, regulation, and function. Int Rev Cytol 111:143-84PubMedGoogle Scholar
  11. Bazan NG (2005) Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol Neurobiol 32(1):89-103PubMedGoogle Scholar
  12. Beckstead MJ, Grandy DK, Wickman K, Williams JT (2004) Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 42(6):939-46PubMedGoogle Scholar
  13. Bender VA, Bender KJ, Brasier DJ, Feldman DE (2006) Two Coincidence Detectors for Spike Timing-Dependent Plasticity in Somatosensory Cortex. J Neurosci 26:4166-77PubMedGoogle Scholar
  14. Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z, Bisogno T, De Petrocellis L, Di Marzo V, Mechoulam R (1998) An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity, Eur J Pharm 353(1):23-31Google Scholar
  15. Bisogno T, Sepe N, Melck D, Maurelli S, De Petrocellis L, Di Marzo V (1997) Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem J 322( Pt 2):671-7PubMedGoogle Scholar
  16. Bisogno T, Melck D, De Petrocellis L, Di Marzo V (1999) Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin. J Neurochem 72(5):2113-19PubMedGoogle Scholar
  17. Bisogno T, Melck D, Bobrov MY, Gretskaya NM, Bezuglov VV, De Petrocellis L, Di Marzo V (2000) N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem J 351 Pt 3:817-24Google Scholar
  18. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano Moriello A, Paul P, Gangadharan U, Hobbs C, Di Marzo V, Doherty P (2003) Cloning of the first sn 1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signalling in the brain. J Cell Biol 163:463-8PubMedGoogle Scholar
  19. Bodor AL, Katona I, Nyiri G, Mackie K, Ledent C, Hajos N, Freund TF (2005) Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 25:6845-56PubMedGoogle Scholar
  20. Bojesen IN, Hansen HS (2003) Binding of anandamide to bovine serum albumin. J Lipid Res 44(9):1790-4PubMedGoogle Scholar
  21. Bojesen IN, Hansen HS (2005) Membrane transport of anandamide through resealed human red blood cell membranes. J Lipid Res 46(8):1652-9PubMedGoogle Scholar
  22. Bortolato M, Campolongo P, Mangieri RA, Scattoni ML, Frau R, Trezza V, La Rana G, Russo R, Calignano A, Gessa GL, Cuomo V, Piomelli D (2006) Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharm 31(12):2652-9Google Scholar
  23. Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F, Calandra B, Pecceu F, Lupker J, Maffrand JP, Le Fur G, Casellas P (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J Biol Chem 272(35):22330-9PubMedGoogle Scholar
  24. Bolshakov VY, Siegelbaum S (1994) Postsynaptic induction and presynaptic expression of hippocampal long-term depression. Science 264(5162):1148-52PubMedGoogle Scholar
  25. Bramham CR, Messaoudi E (2004) BDNF as a trigger for transsynaptic consolidation in the adult brain. In: Stanton PK, Bramham C, Scharfman H (eds) Synaptic plasticity and transsynaptic signaling. Spinger, New York, pp. 159-84Google Scholar
  26. Breivogel CS, Selley SE, Childers SR (1998) Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J Biol Chem 273(27):16865-73PubMedGoogle Scholar
  27. Brenowitz SD, Regehr WG (2005) Associative short-term synaptic plasticity mediated by endocannabinoids. Neuron 45(3):419-31PubMedGoogle Scholar
  28. Brown SP, Brenowitz SD, Regehr WG (2003) Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids. Nat Neurosci 6:1048-57PubMedGoogle Scholar
  29. Brown SP, Safo PK, Regehr WG (2004) Endocannabinoids inhibit transmission at granule cell to Purkinje cell synapses by modulating three types of presynaptic calcium channels. J Neurosci 24 (24):5623-31PubMedGoogle Scholar
  30. Brundege JM, Dunwiddie TV (1996) Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons. J Neurosci 16:5603-12PubMedGoogle Scholar
  31. Burkey TH, Quock RM, Consroe P, Ehlert FJ, Hosohata Y, Roeske WR, Yamamura HI (1997) Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. Eur J Pharmacol 336 (2-3):295-8PubMedGoogle Scholar
  32. Calabresi P, Maj R, Mercuri NB, Bernardi G (1992a) Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum. Neurosci Lett 142(1):95-9Google Scholar
  33. Calabresi P, Maj R, Pisani A, Mercuri NB, Bernardi G (1992b) Long-term synaptic depression in the striatum: physiological and pharmacological characterization, J Neurosci 12:4224-33Google Scholar
  34. Calabresi P, Pisani A, Mercuri NB, Bernardi G (1994) Post-receptor mechanisms underlying striatal long-term depression. J Neurosci 14(8):4871-81PubMedGoogle Scholar
  35. Carlson G, Wang Y, Alger BE (2002) Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat Neurosci 5:723-24PubMedGoogle Scholar
  36. Carlsson A (1993) Thirty years of dopamine research. Adv Neurol 60:1-610PubMedGoogle Scholar
  37. Castellucci VF, Carew TJ, Kandel ER (1978) Cellular analysis of long-term habituation of the gill-withdrawal reflex of Aplysia californica. Science 202(4374):1306-8PubMedGoogle Scholar
  38. Cepeda C, Buchwald NA, Levine MS (1993) Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc Natl Acad Sci USA 90(20):9576-80PubMedGoogle Scholar
  39. Chevaleyre V, Castillo PE (2003) Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38:461-72PubMedGoogle Scholar
  40. Chevaleyre V, Castillo PE (2004) Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron 43(6):871-81PubMedGoogle Scholar
  41. Chevaleyre V, Hefeits BD, Kaeser P, Sudhof TC, Castillo PE (2006) Endocannabinoids target the release machinery via protein kinase A to mediate LTD at inhibitory synapses in both hippocampus and amygdala. Soc Neurosci Abstr 41.11Google Scholar
  42. Chevaleyre V, Takahashi KA, Castillo PE (2006) Endocannabinoid-mediated synaptic plasticity in the CNS. Ann Rev Neurosci 29:37-76PubMedGoogle Scholar
  43. Choi S, Lovinger DM (1997a) Decreased probability of neurotransmitter release underlies striatal long-term depression and postnatal development of corticostriatal synapses. Proc Natl Acad Sci USA 94:2665-70Google Scholar
  44. Choi S, Lovinger DM (1997b) Decreased frequency but not amplitude of quantal synaptic responses associated with expression of corticostriatal long-term depression. J Neurosci 17:861-320Google Scholar
  45. Clapham DE, Neer EJ (1997) G protein beta gamma subunits. Annu Rev Pharmacol Toxicol 37:167-203PubMedGoogle Scholar
  46. Connell K, Bolton N, Olsen D, Piomelli D, Hohmann AG (2006) Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia. Neurosci Lett 397 (3):180-4PubMedGoogle Scholar
  47. Coutts AA, Pertwee RG (1997) Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br J Pharmacol 121(8):1557-66PubMedGoogle Scholar
  48. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature (Lond.) 384:83-7Google Scholar
  49. Croci T, Manara L, Aureggi G, Guagnini F, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Mukenge S, Ferla G (1998) In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Br J Pharmacol 125(7):1393-5PubMedGoogle Scholar
  50. Crozier RA, Wang Y, Liu CH, Bear MF (2007) Deprivation-induced synaptic depression by distinct mechanisms in different layers of mouse visual cortex. Proc Natl Acad Sci USA 2007 104 (4):1383-8PubMedGoogle Scholar
  51. Daniel H, Crepel F (2001) Control of Ca(2+) influx by cannabinoid and metabotropic glutamate receptors in rat cerebellar cortex requires K(+) channels. J Physiol 537(Pt 3):793-800PubMedGoogle Scholar
  52. Davis MI, Ronesi J, Lovinger DM (2003) A predominant role for inhibition of the adenylate cyclase/protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells. J Biol Chem 278(49):48973-80PubMedGoogle Scholar
  53. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-9PubMedGoogle Scholar
  54. Di S, Boudaba C, Popescu IR, Weng FJ, Harris C, Marcheselli VL, Bazan NG, Tasker JG (2005) Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. J Physiol 569:751-60PubMedGoogle Scholar
  55. Diana MA, Marty A (2003) Characterization of depolarization-induced suppression of inhibition using paired interneuron-Purkinje cell recordings. J Neurosci 23:5906-18PubMedGoogle Scholar
  56. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-91PubMedGoogle Scholar
  57. Dinh TP, Carpenter D, Leslien FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99(16):10819-24PubMedGoogle Scholar
  58. Dolphin AC (2003) G protein modulation of voltage-gated calcium channels. Pharmacol Rev 55(4):607-27PubMedGoogle Scholar
  59. Domenici MR, Azad SC, Marsicano G, Schierloh A, Wotjak CT, Dodt HU, Zieglgansberger W, Lutz B, Rammes G (2006) Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J Neurosci 26 (21):5794-9PubMedGoogle Scholar
  60. Dunwiddie TV, Lovinger DM (eds.) (1993) Presynaptic Receptors in the Mammalian Brain. Birkhauser, Boston.Google Scholar
  61. Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31-55PubMedGoogle Scholar
  62. Edwards DA, Kim J, Alger BE (2006) Multiple mechanisms of endocannabinoid response initiation in hippocampus. J. Neurophysiol. 95(1):67-75PubMedGoogle Scholar
  63. Elmslie KS (2003) Neurotransmitter modulation of neuronal calcium channels. J Bioenerg Biomembr 35(6):477-89PubMedGoogle Scholar
  64. Fegley D, Kathuria S, Mercier R, Li C, Goutopoulos A, Makriyannis A, Piomelli D (2004) Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc Natl Acad Sci USA 101(23):8756-61PubMedGoogle Scholar
  65. Feinmark SJ, Begum R, Tsetkov E, Goussakov I, Funk CD, Siegelbaum SA, Boshakov VY (2003) 12-lipoxygenase metabolites of arachidonic acid mediate metabotropic glutamate receptor-dependent long-term depression at hippocampal CA3-CA1 synapses. J Neurosci 23 (36):11427-35PubMedGoogle Scholar
  66. Flores-Hernandez J, Galarraga E, Bargas J (1997) Dopamine selects glutamatergic inputs to neostriatal neurons. Synapse 25(2):185-95PubMedGoogle Scholar
  67. Foldy C, Neu A, Jones MV, Soltesz I (2006) Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J Neurosci 26(5):1465-9PubMedGoogle Scholar
  68. Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017-66PubMedGoogle Scholar
  69. French ED (1997) 9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neurosci Lett 226:159-62PubMedGoogle Scholar
  70. Fukudome Y, Ohno-Shosaku T, Matsui M, Omori Y, Fukaya M, Tsubokawa H, Taketo MM, Watanabe M, Manabe T, Kano M (2004) Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling. Eur J Neurosci 19:2682-92PubMedGoogle Scholar
  71. Galante M, Diana MA (2004) Group I metabotropic glutamate receptors inhibit GABA release at interneuron-Purkinje cell synapses through endocannabinoid production. J Neurosci 24 (20):4865-74PubMedGoogle Scholar
  72. Gardner EL, Paredes W, Smith D, Donner A, Milling C, Cohen D, Morrison D (1988) Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol. Psychopharmacology (Berl) 96:142-4Google Scholar
  73. Gerdeman G, Lovinger DM (2001) CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol 85:468-71PubMedGoogle Scholar
  74. Gerdeman GL, Ronesi J, Lovinger DM (2002) Postsynaptic endocannabinoid release is necessary for long-term depression in the striatum. Nat Neurosci 5(5):446-51PubMedGoogle Scholar
  75. Gerdeman GL, Lovinger DM (2003) Emerging roles for endocannabinoids in long-term synaptic plasticity. Br J Pharmacol 140(5):781-9PubMedGoogle Scholar
  76. Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonseca F, Navarro M, Piomelli D (1999) Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat Neurosci 2:358-63PubMedGoogle Scholar
  77. Glaser ST, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, Deutsch DG (2003) Evidence against the presence of an anandamide transporter. Proc Natl Acad Sci USA 100(7):4269-74PubMedGoogle Scholar
  78. Glass M, Felder CC (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 recep-tors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 17(14):5327-33PubMedGoogle Scholar
  79. Glass M, Northup JK (1999) Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors. Mol Pharmacol 56(6):1362-9PubMedGoogle Scholar
  80. Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, Cuomo V, Piomelli D (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 102 (51):18620-5PubMedGoogle Scholar
  81. Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, Uhl GR (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Br Res 1071(1):10-23Google Scholar
  82. Graham JD, Lewis MJ, Li DM (1974) The effect of delta1-tetrahydrocannabinol on the release of (3H-(-)-noradrenaline from the isolated vas deferens of the rat. Br J Pharmacol 52(2):233-6PubMedGoogle Scholar
  83. Gubellini P, Saulle E, Centonze D, Bonsi P, Pisani A, Bernardi G, Conquet F, Calabresi P (2001) Selective involvement of mGlu1 receptors in corticostriatal LTD. Neuropharm 40:839-46Google Scholar
  84. Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, Freund TF (2004) Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci 20(2):441-58PubMedGoogle Scholar
  85. Guo J, Ikeda SR (2004) Endocannabinoids modulate N-type calcium channels and G-proteincoupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Mol Pharmacol 65(3):665-74PubMedGoogle Scholar
  86. Hajos N, Ledent C, Freund TF (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neurosci 106(1):1-4Google Scholar
  87. Hampson RE, Deadwyler SA (1998) Role of cannabinoid receptors in memory storage. Neurobiol Dis 5(6 Pt B):474-82PubMedGoogle Scholar
  88. Hashimotodani Y, Ohno-Shosaku T, Tsubokawa H, Ogata H, Emoto K, Maejima T, Araishi K, Shin HS, Kano M (2005) Phospholipase Cbeta serves as a coincidence detector through its Ca2+ dependency for triggering retrograde endocannabinoid signal. Neuron 45(2):257-68PubMedGoogle Scholar
  89. Heifets BD, Chevaleyre V, Castillo PE (2006) Interneuron activity dependence of endocannabinoid mediated long term of depression of inhibition (I-LTD) in hippocampus. Soc Neurosci Abstracts 41:12Google Scholar
  90. Heinbockel T, Brager DH, Reich CG, Zhao J, Muralidharan S, Alger BE, Kao J (2005) Endocannabinoid signaling dynamics probed with optical tools. J Neurosci 25(41):9449-59PubMedGoogle Scholar
  91. Hillard CJ, Jarrahian A (2000) The movement of N -arachidonoylethanolamine (anandamide) across cellular membranes. Chem Phys Lipids 108:123-34PubMedGoogle Scholar
  92. Henry DJ, Chavkin C (1995) Activation of inwardly rectifying potassium channels (GIRK1) by coexpressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci Lett 186(2-3):91-4PubMedGoogle Scholar
  93. Hentges ST, Low MJ, Williams JT (2005) Differential regulation of synaptic inputs by constitu-tively released endocannabinoids and exogenous cannabinoids. J Neurosci 25(42):9746-51PubMedGoogle Scholar
  94. Hoffman AF, Lupica CR (2001) Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J Neurophysiol 85:72-83PubMedGoogle Scholar
  95. Hoffman AF, Macgill AM, Smith D, Oz M, Lupica CR (2005) Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus. Eur J Neurosci 22(9):2387-91PubMedGoogle Scholar
  96. Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey JF, Walker JM, Holmes PV, Crystal JD, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D (2005) An endocannabinoid mechanism for stress-induced analgesia. Nature 435(7045):1108-12PubMedGoogle Scholar
  97. Howlett AC, Qualy JM, Khachatrian LL (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 29(3):307-13PubMedGoogle Scholar
  98. Hsu K-T, Storch J (1996) Fatty acid transfer from liver and intestinal fatty acid-binding proteins to membranes occurs by different mechanisms. J Biol Chem 271(23):13317—23PubMedGoogle Scholar
  99. Huang CC, Lo SW, Hsu KS (2001) Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J Physiol 532:731-48PubMedGoogle Scholar
  100. Huang YC, Wang SJ, Chiou LC, Gean PW (2003) Mediation of amphetamine-induced long-term depression of synaptic transmission by CB1 cannabinoid receptors in the rat amygdala. J Neurosci 23(32):10311-20PubMedGoogle Scholar
  101. Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA, (2001) Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiat 58:322-8PubMedGoogle Scholar
  102. Ishac EJ, Jiang L, Lake KD, Varga K, Abood ME, Kunos G (1996) Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118(8):2023-8PubMedGoogle Scholar
  103. Isokawa M, Alger BE (2005) Retrograde endocannabinoid regulation of GABAergic inhibition in the rat dentate gyrus granule cell. J Physiol 567(Pt 3):1001-10PubMedGoogle Scholar
  104. Ito M (2001) Cerebellar long-term depression: characterization, signal transduction, and functional roles. Physiol Rev 81(3):1143-95PubMedGoogle Scholar
  105. Ito M, Kano M (1982) Long-lasting depression of parallel fiber-Purkinje cell transmission induced by conjunctive stimulation of parallel fibers and climbing fibers in the cerebellar cortex. Neurosci Lett 33:253-8PubMedGoogle Scholar
  106. Jo YH, Chen YJ, Chua SC Jr, Talmage DA, Role LW (2005) Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 48(6):1055-66PubMedGoogle Scholar
  107. Jung KM, Mangieri R, Stapleton C, Kim J, Fegley D, Wallace M, Mackie K, Piomelli D (2005) Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol Pharmacol 68(5):1196-1202PubMedGoogle Scholar
  108. Justinova Z, Tanda G, Redhi GH, Goldberg SR (2003) Self-administration of Δ9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology 169: 135-40PubMedGoogle Scholar
  109. Kahn L, Alonso G, Robbe D, Bockaert J, Manzoni OJ (2001) Group 2 metabotropic glutamate receptors induced long term depression in mouse striatal slices. Neurosci Lett 316(3):178-82PubMedGoogle Scholar
  110. Kamprath K, Marsicano G, Tang J, Monory K, Bisogno T, Di Marzo V, Lutz B, Wotjak CT (2006) Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. J Neurosci 26 (25):6677-86PubMedGoogle Scholar
  111. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21(23):9506-18PubMedGoogle Scholar
  112. Katona I, Urban GM, Wallace M, Ledent C, Jung KM, Piomelli D, Mackie K, Freund TF (2006) Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26 (21):5628-37PubMedGoogle Scholar
  113. Kawamura Y, Fukaya M, Maejima T, Yoshida T, Miura E, Watanabe M, Ohno-Shosaku T, Kano M (2006) The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci 26(11):2991-3001PubMedGoogle Scholar
  114. Kim J, Alger BE (2004) Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7(7):697-8PubMedGoogle Scholar
  115. Kobayashi K, Manabe T, Takahashi T (1996) Presynaptic long-term depression at the hippocampal mossy fiber-CA3 synapse. Science 273(5275):648-50PubMedGoogle Scholar
  116. Kozak KR, Crews BC, Morrow JD, Wang LH, Ma YH, Weinander R, Jakobsson PJ, Marnett LJ (2002) Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J Biol Chem 277 (47):44877-85PubMedGoogle Scholar
  117. Kreitzer AC, Malenka RC (2005) Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J Neurosci 25(45):10537-45PubMedGoogle Scholar
  118. Kreitzer AC, Regehr WG (2001) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto purkinje cells. Neuron 29:717-27PubMedGoogle Scholar
  119. Kreitzer AC, Carter AG, Regehr WG (2002) Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum. Neuron 34:787-96PubMedGoogle Scholar
  120. Kulkarni-Narla A, Brown DR (2000) Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system. Cell Tissue Res 302(1):73-80PubMedGoogle Scholar
  121. Kushmerick C, Price GD, Taschenberger H, Puente N, Renden R, Wadiche JI, Duvoisin RM, Grandes P, von Gersdorff H (2004) Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse. J Neurosci 24 (26):5955-65PubMedGoogle Scholar
  122. Kyrozis A, Benameur K, Zhang X-L, Winterer J, Muller W, Stanton PK (2004) Retrograde messengers in long-term plasticity of presynaptic glutamate release in hippocampus. In: Stanton PK, Bramham C, Scharfman H (eds) Synaptic plasticity and transsynaptic signaling. Spinger, New York pp. 273-304Google Scholar
  123. Laviolette SR, Grace AA (2006) Cannabinoids Potentiate Emotional Learning Plasticity in Neurons of the Medial Prefrontal Cortex through Basolateral Amygdala Inputs. J Neurosci 26 (24):6458-68PubMedGoogle Scholar
  124. Lichtman AH (2000) SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats. Eur J Pharmacol 404(1-2):175-9PubMedGoogle Scholar
  125. Lichtman AH, Hawkins EG, Griffin G, Cravatt BF (2002) Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J Pharmacol Exp Ther 302(1):73-9PubMedGoogle Scholar
  126. Liu J, Wang L, Harvey-White J, Osei-Hyiaman D, Razdan R, Gong Q, Chan AC, Zhou Z, Huang B, Kim H-Y, Kunos G (2006) A biosynthetic pathway for anandamide. Proc Natl Acad Sci USA 103 (36):13345-50PubMedGoogle Scholar
  127. Llano I, Leresche N, Marty A (1991) Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents. Neuron 6:565-74PubMedGoogle Scholar
  128. Lefkowitz RJ, Cotecchia S, Samama P, Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14(8):303-7PubMedGoogle Scholar
  129. Levenes C, Daniel H, Soubrie P, Crepel F (1998) Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells. J Physiol 510:867-79PubMedGoogle Scholar
  130. Lopez-Redondo F, Lees GM, Pertwee RG (1997) Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum. Br J Pharmacol 122 (2):330-4PubMedGoogle Scholar
  131. Lovinger DM, Merritt A, Reyes D (1994) Involvement of N- and non-N-type calcium channels in synaptic transmission at corticostriatal synapses. Neurosci 62(1):31-40Google Scholar
  132. McAllister SD, Griffin G, Satin LS, Abood ME (1999) Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system. J Pharmacol Exp Ther 291(2):618-26PubMedGoogle Scholar
  133. Maccarrone M, Bari M, Battista N, Finazzi-Agr ò A (2002) Estrogen stimulates arachi-donoylethanolamide release from human endothelial cells and platelet activation. Blood 100:4040-8PubMedGoogle Scholar
  134. McEachern JC, Shaw CA (1996) An alternative to the LTP orthodoxy: a plasticity-pathology continuum model. Brain Res Brain Res Rev 22(1):51-92PubMedGoogle Scholar
  135. Mackie K, Lai Y, Westenbroek R, Mitchell R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15(10):6552-61PubMedGoogle Scholar
  136. Mackie K, Devane WA, Hille B (1993) Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 44(3):498-503PubMedGoogle Scholar
  137. Mackie K, Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89(9):3825-9PubMedGoogle Scholar
  138. Mackie K (2005) Distribution of cannabinoid receptors in the central and peripheral nervous system. Handbook Exper Pharmacol 168:299-325Google Scholar
  139. Mackie K. (2006) Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength. Int. J. Obes. (Lond.) 30 Suppl 1:S19-23Google Scholar
  140. Mckinney MK, Cravatt, BP (2005) Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74:411-32PubMedGoogle Scholar
  141. Madison DV, Schuman EM (1995) Diffusible messengers and intercellular signaling: locally distributed synaptic potentiation in the hippocampus. Curr Top Microbiol Immunol 196:5-6PubMedGoogle Scholar
  142. Maejima T, Hashimoto K, Yoshida T, Aiba A, Kano M (2001) Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31:463-75PubMedGoogle Scholar
  143. Maejima T, Oka S, Hashimotodani Y, Ohno-Shosaku T, Aiba A, Wu D, Waku K, Sugiura T, Kano M (2005) Synaptically driven endocannabinoid release requires Ca2+assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum. J Neurosci 25(29):6826-35PubMedGoogle Scholar
  144. Makara JK, Mor M, Fegley D, Szabo SI, Kathuria S, Astarita G, Duranti A, Tontini A, Tarzia G, Rivara S, Freund TF, Piomelli D (2005) Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7(7):697-8Google Scholar
  145. Makriyannis A, Guo J, Tian X (2005a) Albumin enhances the diffusion of lipophilic drugs into the membrane bilayer. Life Sci 77(14):1605-11Google Scholar
  146. Makriyannis A, Tian X, Guo J (2005b) How lipophilic cannabinergic ligands reach their receptor sites. Prostaglandins Other Lipid Mediat 7(1-4):210-18Google Scholar
  147. Malenka RC, Bear MF (2004) LTP and LTD: an embarrassment of riches. Neuron 44(1):5-21PubMedGoogle Scholar
  148. Mallet PE, Beninger RJ (1998) The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. Psychopharm (Berl.) 140(1):11-19Google Scholar
  149. Mang CF, Erbelding D, Kilbinger H (2001) Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors. Br J Pharmacol 134(1):161-7PubMedGoogle Scholar
  150. Mansbach RS, Rovetti CC, Winston EN, Lowe JA 3rd. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. Psychopharmacology (Berl). 1996 Apr; 124(4):315-22Google Scholar
  151. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgansberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418(6897):530-4PubMedGoogle Scholar
  152. Martin LA, Alger BE (1999) Muscarinic facilitation of the occurrence of depolarization-induced suppression of inhibition in rat hippocampus. Neurosci 92(1):61-71Google Scholar
  153. Mato S, Robbe D, Puente N, Grandes P, Manzoni OJ (2005) Presynaptic homeostatic plasticity rescues long-term depression after chronic Delta 9-tetrahydrocannabinol exposure. J Neurosci 25 (50):11619-627PubMedGoogle Scholar
  154. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-4PubMedGoogle Scholar
  155. Mazzola C, Micale V, Drago F (2003) Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade. Eur J Pharmacol 477(3):219-25PubMedGoogle Scholar
  156. McFarland MJ, Barker EL (2004) Anandamide transport. Pharmacol Ther 104(2):117-35PubMedGoogle Scholar
  157. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50(1):83-90PubMedGoogle Scholar
  158. Mechoulam R, Deutsch DG (2005) Toward an anandamide transporter. Proc Natl Acad Sci USA 102(49):17541-2PubMedGoogle Scholar
  159. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL (2004a) Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 24(1):53-62Google Scholar
  160. Melis M, Perra S, Muntoni AL, Pillolla G, Lutz B, Marsicano G, Di Marzo V, Gessa GL, Pistis M (2004b) Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J Neurosci 24(47):10707-15Google Scholar
  161. Miller RJ (1998) Presynaptic receptors. Annu Rev Pharmacol Toxicol 38:201-27PubMedGoogle Scholar
  162. Miller LL, Branconnier RJ (1983) Cannabis: effects on memory and the cholinergic limbic system. Psychol. Bull. 93(3):441-56PubMedGoogle Scholar
  163. Mintz IM, Bean B (1993) GABAB receptor inhibition of P-type Ca2+ channels in central neurons. Neuron 10(5):889-98PubMedGoogle Scholar
  164. Misner DL, Sullivan JM (1999) Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J Neurosci 19:6795-6805PubMedGoogle Scholar
  165. Moore SA, Nomikos GG, Dickason-Chesterfield AK, Schober DA, Schaus JM, Ying BP, Xu YC, Phebus L, Simmons RM, Li D, Iyengar S, Felder CC (2005) Identification of a highaffinity binding site involved in the transport of endocannabinoids. Proc Natl Acad Sci USA 102 (49):17852-7PubMedGoogle Scholar
  166. Morishita W, Kirov SA, Alger BE (1998) Evidence for metabotropic glutamate receptor activation in the induction of depolarization-induced suppression of inhibition in hippocampal CA1. J Neurosci 18(13):4870-82PubMedGoogle Scholar
  167. Mukhtarov M, Ragozzino D, Bregestovski P (2005) Dual Ca2+ modulation of glycinergic synaptic currents in rodent hypoglossal motoneurones. J Physiol 569:817-31PubMedGoogle Scholar
  168. Narasimhan K, Linden DJ (1996) Defining a minimal computational unit for cerebellar long-term depression. Neuron 17(2):333-41PubMedGoogle Scholar
  169. Ng Cheong Ton JM, Gerhardt GA, Friedemann M, Etgen AM, Rose GM, Sharpless NS, Gardner EL (1988) The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study. Brain Res 451:59-68PubMedGoogle Scholar
  170. Nowicky AV, Teyler TJ, Vardaris RM (1987) The modulation of LTP by delta-9-THC in the rat hippocampus in vitro. Brain Res 19:663-72Google Scholar
  171. Ohno-Shosaku T, Maejima T, Kano M (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29:729-38PubMedGoogle Scholar
  172. Ohno-Shosaku T, Shosaku J, Tsubokawa H, Kano M (2002) Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. Eur J Neurosci 15:953-61PubMedGoogle Scholar
  173. de Oliveira Alvares L, Genro BP, Vaz Breda R, Pedroso MF, Da Costa JC, Quillfeldt JA (2006) AM251, a selective antagonist of the CB1 receptor, inhibits the induction of long-term potentiation and induces retrograde amnesia in rats. Brain Res 1075(1):60-7PubMedGoogle Scholar
  174. Olson PA, Tkatch T, Hernandez-Lopez S, Ulrich S, Ilijic E, Mugnaini E, Zhang H, Bezprozvanny I, Surmeier DJ (2005) G-protein-coupled receptor modulation of striatal CaV1.3 L-type Ca2+ channels is dependent on a Shank-binding domain. J Neurosci 25(5):1050-62PubMedGoogle Scholar
  175. Orsnes G, Crone C, Krarup C, Petersen N, Nielsen J (2000) The effect of baclofen on the transmission in spinal pathways in spastic multiple sclerosis patients. Clin Neurophysiol 111(8):1372-9PubMedGoogle Scholar
  176. Pan X, Ikeda SR, Lewis DL (1996) Rat brain cannabinoid receptor modulates N-type Ca2+ channels in a neuronal expression system. Mol Pharmacol 49(4):707-14PubMedGoogle Scholar
  177. Pan X, Ikeda SR, Lewis DL (1998) SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity. Mol Pharmacol 54(6):1064-72PubMedGoogle Scholar
  178. Parolaro D, Vigano D, Rubino T (2005) Endocannabinoids and drug dependence. Curr Drug Targets CNS Neurol Disord 4:643-55PubMedGoogle Scholar
  179. Perio, A, Rinaldi-Carmona, M, Maruani, J, Barth, F, Le Fur, G, Sobrie, P. Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A. Behav Pharmacol. 1996 Jan; 7(1):65-71PubMedGoogle Scholar
  180. Pertwee RG, Fernando SR (1996) Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br J Pharmacol 118(8):2053-8PubMedGoogle Scholar
  181. Pitler TA, Alger BE (1992) Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. J Neurosci 12:4122-32PubMedGoogle Scholar
  182. Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P, Bymaster FP, Leese AB, Felder CC (2002) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 301(3):1020-4PubMedGoogle Scholar
  183. Rancillac A, Barbara JG (2005) Frequency-dependent recruitment of inhibition mediated by stellate cells in the rat cerebellar cortex. J Neurosci Res 80(3):414-23PubMedGoogle Scholar
  184. Ralevic V (2003) Cannabinoid modulation of peripheral autonomic and sensory neurotransmission. Eur J Pharmacol 472(1-2):1-21PubMedGoogle Scholar
  185. Reisine T, Pasternak G (1996) Opioid analgesics and antagonists in Goodman & Gilman’s The pharmacological basis of therapeutics. McGraw-Hill (New York, USA) pp. 521-56Google Scholar
  186. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D, Ferrara P, Sobrie P, Breliere JC, Le Fur GL (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240PubMedGoogle Scholar
  187. Robbe D, Alonso G, Duchamp F, Bockaert J, Manzoni OJ (2001) Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J Neurosci 21:109-16PubMedGoogle Scholar
  188. Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ (2002) Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci USA 99:8384-8PubMedGoogle Scholar
  189. Ronesi J, Gerdeman GL, Lovinger DM (2004) Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport. J Neurosci 24(7):1673-9PubMedGoogle Scholar
  190. Rumsey CC, Abbott LF (2006) Synaptic democracy in active dendrites. J Neurophysiol 96(5):2307-18PubMedGoogle Scholar
  191. Saario SM, Savinainen JR, Laitinen JT, Jarvinen T, Niemi R (2004) Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem Pharmacol 67(7):1381-7PubMedGoogle Scholar
  192. Sacchettini JC, Gordon JI (1993) Rat intestinal fatty acid binding protein. A model system for analyzing the forces that can bind fatty acids to proteins. J Biol Chem 268:18399-402PubMedGoogle Scholar
  193. Safo PK, Regehr WG (2005) Endocannabinoids control the induction of cerebellar LTD. Neuron 48:647-59PubMedGoogle Scholar
  194. Sargent Jones L (2005) Recent advances in the role of integrins in developmental and adult synaptic plasticity. In: Stanton PK, Bramham C, Scharfman H (eds) Synaptic plasticity and transsynaptic signaling. Spinger, New York, pp. 457-68Google Scholar
  195. Schmid HHO, Schmid PC, Natarajan V (1990) N -Acylated glycerophospholipids and their derivatives. Prog Lipid Res 29:1-43PubMedGoogle Scholar
  196. Shiflett MW, Rankin AZ, Tomaszycki ML, DeVoogd TJ (2004) Cannabinoid inhibition improves memory in food-storing birds, but with a cost. Proc Biol Sci 271(1552):2043-8PubMedGoogle Scholar
  197. Sjostrom PJ, Turrigiano GG, Nelson SB (2003) Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors. Neuron 39(4):641-54PubMedGoogle Scholar
  198. Slanina KA, Roberto M, Schweitzer P (2005) Endocannabinoids restrict hippocampal long-term potentiation via CB1. Neuropharm 49(5):660-8Google Scholar
  199. Soler-Llavina GJ, Sabatini BL (2006) Synapse-specific plasticity and compartmentalized signaling in cerebellar stellate cells. Nat Neurosci 9(6):798-806PubMedGoogle Scholar
  200. Stanton PK, Bramham C, Scharfman H (eds) (2005) Synaptic plasticity and transsynaptic signaling. Spinger, New York pp. 457-68Google Scholar
  201. Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates longterm potentiation. Nature 388:773-8PubMedGoogle Scholar
  202. Sternweiss PC, Smrcka AV, Gutowski S (1992) Hormone signalling via G-protein: regulation of phosphatidylinositol 4,5-bisphosphate hydrolysis by Gq. Philos Trans R Soc Lond B Biol Sci 336 (1276):35-41Google Scholar
  203. Straiker A, Mackie K (2005) Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. J Physiol 569(Pt 2):501-17PubMedGoogle Scholar
  204. Sullivan JM (2000) Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids. Learn Mem 7(3):132-9PubMedGoogle Scholar
  205. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215(1):89-97PubMedGoogle Scholar
  206. Sung KW, Choi S, Lovinger DM (2001) Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. J Neurophysiol 86:2405-12PubMedGoogle Scholar
  207. Suzuki A, Josselyn SA, Frankland PW, Masushige S, Silva AJ, Kida S (2004) Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci 24 (20):4787-95PubMedGoogle Scholar
  208. Szabo B, Schlicker E (2005) Effects of cannabinoids on neurotransmission. Handbook Exper Pharmacol (168): 327-65Google Scholar
  209. Szabo B, Urbanski MJ, Bisogno T, Di Marzo V, Mendiguren A, Bar W, Freiman I (2006) Depolarization-induced retrograde synaptic inhibition in the cerebellar cortex is mediated by 2-arachidonoylglycerol. J Physiol in press.Google Scholar
  210. Takahashi KA, Castillo PE (2006) The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neurosci 139(3):795-802Google Scholar
  211. Takahashi RN, Pamplona FA, Fernandes MS (2005) The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze. Neurosci Lett 380 (3):270-75PubMedGoogle Scholar
  212. Tanda G, Pontieri FE, Di Chiara G (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common 1 opioid receptor mechanism. Science 27:2048-50Google Scholar
  213. Tanda G, Munzar P, Goldberg SR (2000) Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci 3:1073-4PubMedGoogle Scholar
  214. Tanda G, Goldberg SR (2003) Cannabinoids: reward, dependence, and underlying neurochemical mechanisms-a review of recent preclinical data. Psychopharmacology 169:115PubMedGoogle Scholar
  215. Tang K, Low MJ, Grandy DK, Lovinger DM (2001) Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc Natl Acad Sci USA 98(3):1255-60PubMedGoogle Scholar
  216. Terranova JP, Storme JJ, Lafon N, Perio A, Rinaldi-Carmona M, Le Fur G, Soubrie P (1996) Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology 126(2):165-72PubMedGoogle Scholar
  217. Trettel J, Levine ES (2003) Endocannabinoids mediate rapid retrograde signaling at interneuronpyramidal neuron synapses of the neocortex. J Neurophysiol 89:2334-8PubMedGoogle Scholar
  218. Trettel J, Fortin DA, Levine ES (2004) Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol 556(Pt 1): 95-107PubMedGoogle Scholar
  219. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM (1997) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neurosci 83(2):393-411Google Scholar
  220. Van Beugen BJ, Nagaraja RY, Hansel C (2006) Climbing fiber-evoked endocannabinoid signaling heterosynaptically suppresses presynaptic cerebellar long-term potentiation. J Neurosci 26 (32):8289-94PubMedGoogle Scholar
  221. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, Stella N, Makriyannis A, Piomelli D, Davison JS, Marnett LJ, Di Marzo V, Pittman QJ, Patel KD, Sharkey KA (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310 (5746):329-32PubMedGoogle Scholar
  222. Valjent E, Maldonado R (2000) A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Psychopharmacology (Berl) 147:436-8Google Scholar
  223. Varma N, Carlson GC, Ledent C, Alger BE (2001) Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 21:RC188PubMedGoogle Scholar
  224. Varma N, Brager D, Morishita W, Lenz RA, London B, Alger B (2002) Presynaptic factors in the regulation of DSI expression in hippocampus. Neuropharm 43(4):550-62Google Scholar
  225. Varvel SA, Anum EA, Lichtman AH (2005) Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice. Psychopharm 179(4):863-72Google Scholar
  226. Varvel SA, Lichtman AH (2002) Evaluation of CB1 receptor knockout mice in the Morris water maze. J Pharmacol Exp Ther 301(3):915-24PubMedGoogle Scholar
  227. Vincent P, Marty A (1993) Neighboring cerebellar Purkinje cells communicate via retrograde inhibition of common presynaptic interneurons. Neuron 11:885-93PubMedGoogle Scholar
  228. Volterra A, Meldolesi J (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6(8):626-40PubMedGoogle Scholar
  229. Wagner JJ, Alger BE (1996) Increased neuronal excitability during depolarization-induced suppression of inhibition in rat hippocampus. J Physiol 495(1):107-12PubMedGoogle Scholar
  230. Walsh JP (1993) Depression of excitatory synaptic input in rat striatal neurons. Brain Res 608(1):123-8PubMedGoogle Scholar
  231. Wang J, Zucker RS (2001) Photolysis-induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons. J Physiol 533:757-63PubMedGoogle Scholar
  232. Wang Z, Kai L, Day M, Ronesi J, Yin HH, Ding J, Tkatch T, Lovinger D, Surmeier DJ (2006) Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 50:443-52PubMedGoogle Scholar
  233. Wartmann M, Campbell D, Subramanian A, Burstein SH, Davis RJ (1995) The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett 359 (2-3):133-6PubMedGoogle Scholar
  234. Wei BQ, Mikkelsen TS, McKinney MK, Lander ES, Cravatt BF (2006) A second fatty acid amide hydrolase with variable distribution among placental mammals. J Biol Chem 281(48): 36569-78PubMedGoogle Scholar
  235. Weisskopf MG, Zalutsky RA, Nicoll RA (1993) The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 362(6419):423-7PubMedGoogle Scholar
  236. Wigstrom H, Gustafsson B (1986) Postsynaptic control of hippocampal long-term potentiation. J Physiol (Paris) 81(4):228-36Google Scholar
  237. Wiley JL, Martin BR (1999) Effects of SR141716A on diazepam substitution for delta-9tetrahydrocannabinol in rat drug discrimination. Pharmacol Biochem Behav 64:519PubMedGoogle Scholar
  238. Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588-92PubMedGoogle Scholar
  239. Wilson RI, Kunos G, Nicoll RA (2001) Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31(3):453-62PubMedGoogle Scholar
  240. Wolf MC, Leander JD (2003) SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task. Eur J Pharmacol 477(3):213-17Google Scholar
  241. Wu L-G, Saggau P (1997) Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci 20(5): 204-12PubMedGoogle Scholar
  242. Yanovsky Y, Mades S, Misgeld U (2003) Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra. Neurosci 122:317-238Google Scholar
  243. Yin HH, Ronesi J, Davis M, Lovinger DM (2006) The role of protein synthesis in striatal long-term depression. J Neurosci 26(46):11811-20PubMedGoogle Scholar
  244. Yin HH, Lovinger DM (2006) Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc Natl Acad Sci USA 103(21): 8251-6PubMedGoogle Scholar
  245. Yoshida T, Hashimoto K, Zimmer A, Maejima T, Araishi K, Kano M (2002) The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. J Neurosci 22(5):1690-7PubMedGoogle Scholar
  246. Zangen A, Solinas M, Ikemoto S, Goldberg SR, Wise RA (2006) Two brain sites for cannabinoid reward. J Neurosci 26(18):4901-7PubMedGoogle Scholar
  247. Zhu PJ, Lovinger DM (2005) Retrograde endocannabinoid signaling in a postsynaptic neuron/synaptic bouton preparation from basolateral amygdala. J Neurosci 25(26):6199-6207PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • David M. Lovinger
    • 1
  1. 1.Laboratory for Integrative NeuroscienceNational Institute on Alcohol Abuse and Alcoholism, National Institutes of HealthBethesdaUSA

Personalised recommendations